Cargando…
Experimental approach to IGF-1 therapy in CCl(4)-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency
BACKGROUND: Cell necrosis, oxidative damage, and fibrogenesis are involved in cirrhosis development, a condition in which insulin-like growth factor 1 (IGF-1) levels are diminished. This study evaluates whether the exogenous administration of low doses of IGF-1 can induce hepatoprotection in acute c...
Autores principales: | Morales-Garza, Luis A., Puche, Juan E., Aguirre, Gabriel A., Muñoz, Úrsula, García-Magariño, Mariano, De la Garza, Rocío G., Castilla-Cortazar, Inma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418730/ https://www.ncbi.nlm.nih.gov/pubmed/28472963 http://dx.doi.org/10.1186/s12967-017-1198-4 |
Ejemplares similares
-
IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture
por: Lara-Diaz, VJ, et al.
Publicado: (2017) -
Clinical and molecular diagnosis of a cartilage‐hair hypoplasia with IGF‐1 deficiency
por: Castilla‐Cortázar, Inma, et al.
Publicado: (2016) -
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
por: Puche, Juan E, et al.
Publicado: (2012) -
Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins
por: González-Guerra, José Luis, et al.
Publicado: (2017) -
Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome
por: De Ita, J. Rodríguez, et al.
Publicado: (2015)